HRT Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $461K | Buy |
+488,468
| New | +$461K | ﹤0.01% | 1396 |
|
|
2024
Q2 | – | Sell |
-16,965
| Closed | -$40K | – | 2542 |
|
|
2024
Q1 | $40K | Buy |
+16,965
| New | +$40K | ﹤0.01% | 1835 |
|
|
2023
Q3 | – | Sell |
-198,676
| Closed | -$454K | – | 2556 |
|
|
2023
Q2 | $454K | Buy |
+198,676
| New | +$454K | ﹤0.01% | 1282 |
|
|
2022
Q4 | – | Sell |
-45,569
| Closed | -$109K | – | 2647 |
|
|
2022
Q3 | $109K | Buy |
+45,569
| New | +$109K | ﹤0.01% | 2191 |
|
|
2022
Q2 | – | Sell |
-242,211
| Closed | -$506K | – | 3219 |
|
|
2022
Q1 | $506K | Buy |
242,211
+140,650
| +138% | +$294K | ﹤0.01% | 1454 |
|
|
2021
Q4 | $400K | Buy |
+101,561
| New | +$400K | ﹤0.01% | 1848 |
|
|
2020
Q3 | – | Sell |
-31,562
| Closed | -$62K | – | 2065 |
|
|
2020
Q2 | $62K | Buy |
+31,562
| New | +$62K | ﹤0.01% | 1171 |
|
|
2019
Q4 | – | Sell |
-16,364
| Closed | -$49K | – | 1371 |
|
|
2019
Q3 | $49K | Buy |
+16,364
| New | +$49K | ﹤0.01% | 1193 |
|